JPH0567128B2 - - Google Patents

Info

Publication number
JPH0567128B2
JPH0567128B2 JP63019742A JP1974288A JPH0567128B2 JP H0567128 B2 JPH0567128 B2 JP H0567128B2 JP 63019742 A JP63019742 A JP 63019742A JP 1974288 A JP1974288 A JP 1974288A JP H0567128 B2 JPH0567128 B2 JP H0567128B2
Authority
JP
Japan
Prior art keywords
compound
therapeutic agent
present
disease
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63019742A
Other languages
English (en)
Japanese (ja)
Other versions
JPS646214A (en
Inventor
Kazunari Myazaki
Yasuhiko Inoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP63019742A priority Critical patent/JPS646214A/ja
Publication of JPS646214A publication Critical patent/JPS646214A/ja
Publication of JPH0567128B2 publication Critical patent/JPH0567128B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP63019742A 1987-02-13 1988-01-29 Remedy for ulcerative colonopathy Granted JPS646214A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63019742A JPS646214A (en) 1987-02-13 1988-01-29 Remedy for ulcerative colonopathy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3212987 1987-02-13
JP63019742A JPS646214A (en) 1987-02-13 1988-01-29 Remedy for ulcerative colonopathy

Publications (2)

Publication Number Publication Date
JPS646214A JPS646214A (en) 1989-01-10
JPH0567128B2 true JPH0567128B2 (en, 2012) 1993-09-24

Family

ID=12350275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63019742A Granted JPS646214A (en) 1987-02-13 1988-01-29 Remedy for ulcerative colonopathy

Country Status (5)

Country Link
US (1) US4873261A (en, 2012)
EP (1) EP0278497A3 (en, 2012)
JP (1) JPS646214A (en, 2012)
KR (1) KR880009644A (en, 2012)
DK (1) DK72288A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0677419U (ja) * 1993-04-12 1994-10-28 凱士士企業股▲ひん▼有限公司 配線函

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508268A (en) * 1993-08-12 1996-04-16 Bristol-Myers Squibb Parenteral elsamitrucin formulations
KR100651650B1 (ko) * 2000-10-12 2006-11-30 한국화학연구원 아위로부터 분리된 세스키테르펜 화합물을 포함하는 항암제 조성물
WO2011125930A1 (ja) * 2010-04-02 2011-10-13 日本製薬株式会社 炎症性腸疾患又は自己免疫性の末梢神経障害の予防又は治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2405941A1 (fr) * 1977-06-30 1979-05-11 Otsuka Pharma Co Ltd Nouveaux derives sesquiterpeniques utiles notamment comme inhibiteurs du systeme complementaire et leurs procedes de preparation
JPS5630917A (en) * 1979-08-22 1981-03-28 Otsuka Pharmaceut Co Ltd Preventive and remedy for hepatitis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0677419U (ja) * 1993-04-12 1994-10-28 凱士士企業股▲ひん▼有限公司 配線函

Also Published As

Publication number Publication date
KR880009644A (ko) 1988-10-04
EP0278497A3 (en) 1990-05-09
JPS646214A (en) 1989-01-10
EP0278497A2 (en) 1988-08-17
DK72288D0 (da) 1988-02-12
DK72288A (da) 1988-08-14
US4873261A (en) 1989-10-10

Similar Documents

Publication Publication Date Title
CN103059043A (zh) 伸筋草碱a-c、其制法和其药物组合物与用途
EP0579681B1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
US20090246267A1 (en) Carnitine Conjugates of Adamantanamines and Neramexane Derivatives as Dual Prodrugs for Various Uses
CN108218862B (zh) α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用
JPS6126996B2 (en, 2012)
JPH0567128B2 (en, 2012)
JPS6232170B2 (en, 2012)
CN104250247B (zh) 新型槐定碱类衍生物槐定酸、槐定醇、槐定酯、槐定醚及其制备方法和用途
JPS6213952B2 (en, 2012)
JP2018199718A (ja) ３−ホルミルリファマイシンｓｖ及び３−ホルミルリファマイシンｓの３−（４−シンナミル−１−ピペラジニル）アミノ誘導体を含有する医薬製剤並びにこれらの製造方法
JPH08231396A (ja) 抗ヘリコバクター・ピロリ薬
JPS604189B2 (ja) 抗菌剤およびその製法
JPH032183A (ja) ビスベンジルイソキノリン誘導体
US4322555A (en) Nonaprenylamine derivatives
KR20030027119A (ko) 1,3,4-옥사디아졸 유도체의 신규 결정, 그 제조 방법 및그것을 유효 성분으로서 함유하는 약제
EP2789604A1 (en) Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same
JPH03169811A (ja) 糖尿病治療剤
JP4808853B2 (ja) 新規抗腫瘍剤
JPH0481593B2 (en, 2012)
JPS603311B2 (ja) 抗生物質シユ−ドモン酸誘導体およびその製法
JP2025513495A (ja) キラルアリールプロピオン酸誘導体及びその薬物組成物並びにその使用
JPH0826063B2 (ja) ポモール酸及びオレアノール酸誘導体
JPH0368578A (ja) ビスベンジルイソキノリン誘導体
JPH02121982A (ja) エライオフイリン誘導体
KR100359176B1 (ko) 간장질환 예방 및 치료효과를 갖는 2-알릴치오피라진·아스코르빈산염의 조성물 및 그 제조방법